about
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and ef...
Read More
5.65
-0.30
(-5.04%)
2.8M
XNAS Volume
XNAS 06 Nov, 2025 4:30 PM (EST)
Low Financial Strength
Expensive Valuation
Technically Moderately Bullish
Momentum Trap
These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked.
View Similar
Embed DVM
Ardelyx Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..